BioSpace News Archive

Halozyme Therapeutics, Inc. will participate in two upcoming investor conferences.

Industry Leading Conference Rebrands to Showcase Disruption and Innovation in Employer Healthcare, Benefits, and Medical Tourism

According to recent data provided by New Frontier Data, the U.S. CBD industry grew by nearly 40% in 2017, reaching USD 367 Million in sales across hemp-derived and marijuana-derived markets.

Recent data published by Grand View Research Inc., indicates that the global legal cannabis market is projected to reach USD 146.4 Billion by end of 2025.

Provides consultation from board-certified hematologists/oncologists

rfxcel, the leader in track and trace solutions for the pharmaceutical market, today announced tremendous growth in India.

In an historic decision, the American Osteopathic Association’s House of Delegates amended governing documents to allow their MD counterparts full membership in the organization, which represents the interests of the nation’s more than 137,000 osteopathic physicians (DOs) and osteopathic medical students.

ExThera Medical Corporation, a developer of therapies for removing bacteria and viruses from blood, today announced results from a prospective, non-randomized clinical trial evaluating the safety and performance of the Seraph® 100 Microbind® Affinity Blood Filter (Seraph) in renal replacement therapy patients who developed bacteremia

Over 1,600 entrepreneurs, corporations, development organizations, governments, investors and academic institutions from over 64 countries met at the Singularity University (SU) Global Summit to learn more about the application of rapidly accelerating technology to large-scale global issues.

Drug developer Berlin Cures today announced the successful completion of its Phase 1 study of BC 007, a DNA-based aptamer compound that binds to and eliminates functional pathogenic autoantibodies for the treatment of cardiomyopathy.